参考文献/References:
[1] FUHRMANN I K,STEINHAGEN J,RUTHER W,et al.Comparative immunohistochemical evaluation of the zonal distribution of extracellular matrix and inflammation markers in human meniscus in osteoarthritis and rheumatoid arthritis[J].Acta Histochem,2015,117(3):243-254.
[2] 贾丁丁,乔永杰.ESR和CRP对晚期类风湿性关节炎TKA手术风险评估的意义[J].中国骨与关节损伤杂志,2017,32(1):107-109.
[3] DA CORTE F C,NEVES N.Cervical spine instability in arthritis[J].Eur J Orthop Surg Traumatol,2014,24(1):S83-S91.
[4] 高华利,肖涟波.颈椎类风湿关节炎诊治进展[J].中国骨与关节损伤杂志,2015,30(3):332-333.
[5] LEE J K,CHOI C H.Total knee arthroplasty in rheumatoid arthritis[J].Knee Surgery & Related Research,2012,24(1):1-6.
[6] PETERS M J,SYMMONS D P,MCCAREY D,et al.EULAR evidencebased recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis[J].Ann Rheum Dis,2010,69(2):325-331.
[7] AVINA-ZUBIETA J A,THOMAS J,SADATSAFAVI M,et al.Risk of incident cardiovascular events in patientswith rheumatoid arthritis:a meta-analysis of observational studies[J].Ann Rheum Dis,2012,71(9):1524-1529.
[8] BISKUP M,BISKUP W,MAJDAN M,et al.Cardiovascular system changes in rheumatoid arthritis patients with continued low disease activity[J].Rheumatol Int,2018,38(7):1207-1215.
[9] TRIEB K.Arthrodesis of the wrist in rheumatoid arthritis[J].World J Orthop,2014,5(4):512-515.
[10] CHAN F K,LANAS A,SCHEIMAN J,et al. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis(CONDOR):a randomised trial[J].Lancet,2010,376(9736):173-179.
[11] GOODMAN S M,SPRINGER B,YATES A,et al.2017 american college of rheumatology/american association of hip and knee surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty[J].Arthritis & Rheumatology,2017,69(8):1538-1551.
[12] SOMAYAJI R,BARNABE C,MARTIN L.Risk factors for infection following total joint arthroplasty in rheumatoid arthritis[J].Open Rheumatol J,2013,7:119-124.
[13] DIDDLE J W,ALMODOVAR M C,RAJAGOPAL S K,et al.Extracorporeal membrane oxygenation for the support of adults with acute myocarditis[J].Crit Care Med,2015,43(5):1016-1025.
[14] MULLAJI A B,SHETTY G M. Surgical technique:computer-assisted sliding medial condylar osteotomy to achieve gap balance in varus knees during TKA[J]. Clin Orthop Relat Res,2013,471(5):1484-1491.
[15] LACHIEWICZ P F,SOILEAU E S.Results of a second generation constrained condylar prosthesis in primary total knee arthroplasty[J].J Arthroplasty,2011,26(8):1228-1231.
[16] DALE H,FENSTAD A M,HALLAN G,et al. Increasing risk of prosthetic joint infection after total hip arthroplasty[J].Acta Orthop,2012,83(5):449-458.
[17] ZHANG X Z,ZHU W,ZHANG W J.High-flexion posterior-substituting versus cruciate-retaining prosthesis in total knee arthroplasty:functional outcome,range of motion and complication comparison[J].Arch Orthop Trauma Surg,2015,135(1):119-124.
[18] HAMAI S,MIYAHARA H,ESAKI Y.Mid-term clinical results of primary total knee arthroplasty using metal block augmentation and stem extension in patients with rheumatoid arthritis[J].Knee,2017,24(2):409-418.
[19] FLETCHER N,SOFIANOS D M,BERKES M B,et al.Obremskey prevention of perioperative infection[J]. J Bone Joint Surg Am,2007,89(7):1605-1618.
[20] KANCHANABAT B,STAPANAVATR W,MEKNAVIN S,et al.Systematic review and meta-analysis on the rate of postoperative venous thromboembolism in orthopaedic surgery in Asian patients without thromboprophylaxis[J].Br J Surg,2011,98(10):1356-1364.
[21] NIETO J A,ESPADA,N G,MERINO R G.Dabigatran,rivaroxaban and apixaban versus enoxaparin for thomboprophylaxis after total knee or hip arthroplasty:pool-analysis of phase Ⅲ randomized clinical trials[J].Thromb Res,2012,130(2):183-191.